$STAB News February 15, 2022 Statera Biopharma, I
Post# of 37036
Statera Biopharma, Inc., Announces Central Institutional Review Board Approval of Phase 3 Clinical Trial for Pediatric Crohn’s Disease
https://finance.yahoo.com/news/statera-biopha...00996.html